Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifevantage (LFVN) Shares Outstanding (Weighted Average) (2016 - 2025)

Lifevantage's Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $12.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 2.53% year-over-year to $12.5 million; the TTM value through Dec 2025 reached $12.5 million, up 2.53%, while the annual FY2025 figure was $12.3 million, 1.66% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $12.5 million in Q4 2025 per LFVN's latest filing, up from $12.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $14.1 million in Q1 2021 to a low of $12.2 million in Q3 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $12.7 million, with a median of $12.5 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): dropped 8.42% in 2022, then rose 2.53% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $13.2 million in 2021, then decreased by 4.94% to $12.5 million in 2022, then grew by 0.25% to $12.6 million in 2023, then dropped by 2.89% to $12.2 million in 2024, then rose by 2.53% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for LFVN's Shares Outstanding (Weighted Average) are $12.5 million (Q4 2025), $12.4 million (Q3 2025), and $12.3 million (Q2 2025).